Abstract
Long-term Outcomes in Low-Risk Differentiated Papillary Thyroid Cancer
Highlights
I n this issue of Mayo Clinic Proceedings, Hay et al[1] present their analysis of the impact of radioactive iodine remnant ablation (RRA) in low-risk adult papillary thyroid carcinoma (PTC)
As the group eloquently describe, the role of RRA in the management of low-risk patients with PTC has been controversial for decades
Continued pressure from these groups has resulted in recent recognition of the uncertainty of benefit associated with RRA in the majority of patients and as a result, a change in the guidelines to reflect this uncertainty.[6]
Summary
I n this issue of Mayo Clinic Proceedings, Hay et al[1] present their analysis of the impact of radioactive iodine remnant ablation (RRA) in low-risk adult papillary thyroid carcinoma (PTC). As the group eloquently describe, the role of RRA in the management of low-risk patients with PTC has been controversial for decades. This problem highlights the importance of studies drawn from resources such as the Mayo Clinic Rochester papillary thyroid carcinoma database (MRPD).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
